US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 20.860
  • -0.350-1.65%
Trading Nov 21 14:19 ET
1.51BMarket Cap-173833P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
111.60M
112.21M
+615.50K
Beat Est.
+66.45%
+67.37%
+0.55%
EPS
0.03
-0.18
-0.21
Miss Est.
+116.51%
+10.00%
-645.45%
Analyst Rating
Strong Buy

Nov 5, 2024

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 138.406M--
--2024/Q4-- / 123.197M--
Oct 29, 20242024/Q3112.214M / 111.599M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals International Earnings Reports

  • Kiniksa Pharmaceuticals International | 10-Q: Q3 2024 Earnings Report

    Oct 29 16:21 ET

  • Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report

    Jul 25 16:16 ET

  • Kiniksa Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    Apr 25 16:22 ET

  • Kiniksa Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 28 22:32 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 5, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data